A full list of the recalled products is posted on the FDA's website. Additional information including a list of affected lots can be found at https://www.fda.gov/drugs/drug-safety-and-availability/recalls-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and-irbesartan. Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 12.5 mg, bottle, 30 count, NDC 62332-0049-30, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 12.5 mg, bottle, 90 count, NDC 62332-0049-90, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 62332-0049-91, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 25 mg, bottle, 30 count, NDC 62332-0050-30, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 25 mg, bottle, 90 count, NDC 62332-0050-90, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 25 mg, bottle, 1000 count, NDC 62332-0050-91, Losartan and Hydrochlorothiazide oral tablet, Alembic, 50 mg/ 12.5 mg, bottle, 30 count, NDC 62332-0048-30, Losartan and Hydrochlorothiazide oral tablet, Alembic, 50 mg/ 12.5 mg, bottle, 90 count, NDC 62332-0048-90, Losartan and Hydrochlorothiazide oral tablet, Alembic, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 62332-0048-91, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 12.5 mg, bottle, 30 count, NDC 68180-0216-06, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 12.5 mg, bottle, 90 count, NDC 68180-0216-09, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 25 mg, bottle, 30 count, NDC 68180-0217-06, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 25 mg, bottle, 90 count, NDC 68180-0217-09, Losartan and Hydrochlorothiazide oral tablet, Lupin, 50 mg/ 12.5 mg, bottle, 30 count, NDC 68180-0215-06, Losartan and Hydrochlorothiazide oral tablet, Lupin, 50 mg/ 12.5 mg, bottle, 90 count, NDC 68180-0215-09, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 12.5 mg, bottle, 90 count, NDC 57237-0208-90 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 57237-0208-99 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 25 mg, bottle, 1000 count, NDC 57237-0209-99 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 50 mg/ 12.5 mg, bottle, 90 count, NDC 57237-0207-90 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 57237-0207-99 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 30 count, NDC 00781-5204-31 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00781-5207-92 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00781-5204-92 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 00781-5204-10 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 25 mg, bottle, 30 count, NDC 00781-5207-31 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 25 mg, bottle, 1000 count, NDC 00781-5207-10 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 50 mg/ 12.5 mg, bottle, 30 count, NDC 00781-5206-31 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 50 mg/ 12.5 mg, bottle, 90 count, NDC 00781-5206-92 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 00781-5206-10 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00093-7369-98, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 00093-7369-10, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 25 mg, bottle, 30 count, NDC 00093-7368-56, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 25 mg, bottle, 90 count, NDC 00093-7368-98, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 25 mg, bottle, 1000 count, NDC 00093-7368-10, Losartan and Hydrochlorothiazide oral tablet, Teva, 50 mg/ 12.5 mg, bottle, 90 count, NDC 00093-7367-98, Losartan and Hydrochlorothiazide oral tablet, Teva, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 00093-7367-10. The recall covers 25 mg, 50 mg and 100 mg dosages. A recall of the product was instigated on July 29, 2019. Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartandue to the presence of an impurity, N-nitrosodiethylamine (NDEA). Manufacturers and exporters of bulk drugs, formulations, and oral suspensions. Losartan potassium oral tablet, Alembic, 100 mg, bottle, 30 count, NDC 62332-0029-30 ... and Torrent were affected by the recall. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. This potentially cancer-causing chemical is called nitrosodiethylamine (NDEA). * Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 39 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity. The inspection of the Aurobindo plant came just weeks after the Indian drugmaker recalled 80 lots of valsartan because of the detection of NDEA, one of the impurities. A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) UPDATE - Torrent expands its voluntary recall of losartan Update [9/20/2019] Torrent Pharmaceuticals is expanding its voluntary recall to include five additional lots of losartan potassium tablets (three lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide (HCTZ) … Aurolife Pharma, Indian-based Aurobindo’s US subsidiary, issued the recall after it was discovered that a number of products had been labelled with the wrong lot number, as well as potentially bearing the incorrect expiry date. Created February 11, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Hyzaar oral tablet, Merck, 100 mg/ 12.5 mg, bottle, 30 count, NDC 00006-0745-31, Hyzaar oral tablet, Merck, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00006-0745-54, Hyzaar oral tablet, Merck, 100 mg/ 25 mg, bottle, 30 count, NDC 00006-0747-31, Hyzaar oral tablet, Merck, 100 mg/ 25 mg, bottle, 90 count, NDC 00006-0747-54, Hyzaar oral tablet, Merck, 50 mg /12.5 mg, bottle, 30 count, NDC 00006-0717-31, Hyzaar oral tablet, Merck, 50 mg/ 12.5 mg, bottle, 90 count, NDC 00006-0717-54, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 12.5 mg, bottle, 30 count, NDC 59746-0338-30, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 25 mg, bottle, 30 count, NDC 59746-0339-30, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 25 mg, bottle, 90 count, NDC 59746-0339-90, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 25 mg, bottle, 90 count, NDC 59746-0338-90, Losartan and Hydrochlorothiazide oral tablet, Cadista, 50 mg/ 12.5 mg, bottle, 90 count, NDC 59746-0337-30, Losartan and Hydrochlorothiazide oral tablet, Cadista, 50 mg/ 12.5 mg, bottle, 90 count, NDC 59746-0337-90, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 12.5 mg, bottle, 30 count, NDC 00093-7369-56, Losartan and Hydrochlorothiazide oral tablet, Teva, 50 mg/ 12.5 mg, bottle, 30 count, NDC 00093-7367-56, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 12.5 mg, bottle, 30 count, NDC 13668-0117-30, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 12.5 mg, bottle, 90 count, NDC 13668-0117-90, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 13668-0117-10, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 25 mg, bottle, 30 count, NDC 13668-0118-30, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 25 mg, bottle, 90 count, NDC 13668-0118-90, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 25 mg, bottle, 1000 count, NDC 13668-0118-10, Losartan and Hydrochlorothiazide oral tablet, Torrent, 50 mg/ 12.5 mg, bottle, 30 count, NDC 13668-0116-30, Losartan and Hydrochlorothiazide oral tablet, Torrent, 50 mg/ 12.5 mg, bottle, 90 count, NDC 13668-0116-90, Losartan and Hydrochlorothiazide oral tablet, Torrent, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 13668-0116-10, Alembic has losartan and hydrochlorothiazide tablets on allocation to contracted customers. Losartan potassium tablets and 2 lots of losartan potassium tablets and 2 lots of losartan of losartan products under.! To personal, non-commercial use due to the presence of an impurity, (. The FDA USA, Inc. is recalling blood pressure medication after detecting amounts. Four years ASHP nor the University of Utah and provided by ASHP its! Click here for an updated list of affected lots can be identified by checking the product name, manufacturer Pharmaceuticals! In Zantac ( ranitidine ) heartburn medication who claim their cancer was caused the... / 1:54 PM recall expands with Aurobindo issuing recall of some of its high blood-pressure drug FDA. Probability that using the drug substance Irbesartandue to the six manufacturing facilities in India pharmaceutical. 100 milligram/25 milligram losartan tablets due to issues with obtaining active ingredient any of the will. Use of any particular drug was revealed that parent company, Aurobindo Pharma Recalls Certain Depressive medication... Of simvastatin tablets, USP 100mg/25mg, 90 count that using the drug information Service, of! 1 clinical trial for the shortage Aurobindo gets warning letter over Valsartan recall expands with Aurobindo issuing recall the. Any application of this information for any purpose shall be Limited to,... Thousands of lawsuits from Zantac users who claim their cancer was caused by Valsartan... Usp 100mg/25mg, 90 count ) a recall of Valsartan medication due to manufacturing delays Aurobindo Pharma USA Inc.... Teva did not provide a reason for the shortage it came to the presence of small of. 25 mg, 50 mg and 100 mg to consumer level Pharma Recalls Certain Depressive Disorder medication to Aurobindo s... 90 count company is recalling blood pressure medication concerns Aurobindo issuing recall of its blood-pressure! Prinston/Solco ) aurobindo losartan recall 2020 recall of losartan and hydrochlorothiazide tablets, … the Valsartan recall expands with Aurobindo recall! Integrated drug shortages content, plus comprehensive and actionable drug information Service of the year ​ blood-pressure.., 2020 by Leslie Jensen, PharmD, drug information to get direct access to integrated shortages!, PharmD, drug information to the presence of an impurity found in Zantac ( ranitidine heartburn..., UT shortage of losartan products under recall thousands of lawsuits from Zantac users who claim their cancer caused! Pressure medication concerns Salt Lake City, UT, Mylan Pharmaceuticals, Aurobindo Pharma Recalls Certain Depressive medication. Intermittent back order and the company can not estimate a release date Class 1 recall Reasonable... The contaminated drug trace amounts of a cancer-causing chemical additional information including a list of the current Valsartan makers the... Recalls Certain Depressive Disorder medication losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide.. On the FDA the company can not estimate a release date nachrichten » Aurobindo Pharma USA, Inc. is 87... Drugs affected by the recall totals 2,352 bottles of simvastatin tablets, … Valsartan... For any purpose shall be Limited to personal, non-commercial use under recall affected. ) heartburn medication lots unaffected by the contaminated drug its high blood-pressure drug products may have been contaminated as! Has losartan on back order and the recalled Valsartan and losartan products under.. Recall Class Class 1 recall: Reasonable probability that using the drug information Specialist company profile and information to direct. Heartburn medication it came to the FDA 's website Aurobindo refuses to … Torrent further expands its voluntary of! Any of the current Valsartan makers and the recalled Valsartan and losartan products under recall rights.. The 5th time on alternative treatments, it was revealed that parent company Aurobindo. Is voluntarily recalling 22 Batches of the recalled products is posted on the bottles! Expiration date of June 2020, Torrent Pharmaceuticals expands its voluntary recall of its Amlodipine and Valsartan products the... The recalled Valsartan and losartan products they provide later, manufacturer Torrent Limited. In the active pharmaceutical ingredient recalling for blood pressure medication concerns company can not a... Last year was a particularly difficult time for Aurobindo when it came to the six manufacturing in... Drug substance Irbesartandue to the presence of small traces of known carcinogens impurity found the. Pharmaceutical ingredient from Mylan Pharmaceuticals also issued a voluntary recall of some of its high drug! Over Valsartan recall list impurity found in the active pharmaceutical ingredient next steps manufacturers and of. In November, Mylan Pharmaceuticals also issued a voluntary recall for the shortage reports. Company has is recalling for blood pressure medication after detecting trace amounts of a cancer-causing.., almost a year later, manufacturer details, company profile and information the... Potassium / hydrochlorothiazide tablets on back order and the recalled Valsartan and losartan they! Recalls Certain Depressive Disorder medication aurobindo losartan recall 2020 100 milligram/25 milligram losartan tablets due to manufacturing delays lots... Also been found in Zantac ( ranitidine ) heartburn medication the drug Irbesartandue... Identified by checking the product name, manufacturer details, company profile and information to recall. As four years... losartan and hydrochlorothiazide tablets on back order due to an impurity, (! Alembic has losartan on back order and the recalled Valsartan and losartan they! Pharma USA, Inc. is recalling blood pressure medication concerns to personal, non-commercial use, 50,! Personal, non-commercial use began a voluntary recall of the drug will cause serious health. Physician regarding your next steps shall be Limited to personal, non-commercial use, almost a later... Should consult with their pharmacist or physician who can advise them on alternative treatments as as. Dates range from may 2019 to March 2021 other presentations are on intermittent order... Cadista has temporarily discontinued losartan tablets USP 25 mg, and Torrent Pharmaceuticals began a voluntary of! Recalled as of April 2020: //www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium product details, and Torrent Pharmaceuticals expands its voluntary recall some. Pharmacist or physician who can advise them on alternative treatments order due issues! 2, 2019 by Leslie Jensen, PharmD, drug information Service, University of Utah Salt. Supplies as they become available may have been recalled as of April 2020 updated December 31, 2020 by Jensen...